These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 32218590)

  • 1. New strategies for Leptospira vaccine development based on LPS removal.
    Lauretti-Ferreira F; Silva PLD; Alcântara NM; Silva BF; Grabher I; Souza GO; Nakajima E; Akamatsu MA; Vasconcellos SA; Abreu PAE; Carvalho E; Martins EAL; Ho PL; da Silva JB
    PLoS One; 2020; 15(3):e0230460. PubMed ID: 32218590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-protection among unrelated leptospira pathogens serovars: an unfinished story.
    Rosario LA; Arencibia DF; Suarez YE; Infante JF; Valdés BY; Batista N
    Adv Clin Exp Med; 2012; 21(5):581-9. PubMed ID: 23356194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective efficacy of whole-cell inactivated Leptospira vaccines made using virulent or avirulent strains in a hamster model.
    Rodrigues de Oliveira N; Jorge S; Andrade Colares Maia M; Thurow Bunde T; Kurz Pedra AC; Pinto Seixas Neto AC; Larré Oliveira T; Dellagostin OA
    Vaccine; 2021 Sep; 39(39):5626-5634. PubMed ID: 34400016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A canine vaccine against Leptospira serovars Icterohaemorrhagiae, Canicola and Grippotyphosa provides cross protection against Leptospira serovar Copenhageni.
    Bouvet J; Lemaitre L; Cariou C; Scotto M; Blain C; Oberli F; Cupillard L; Guigal PM
    Vet Immunol Immunopathol; 2020 Jan; 219():109985. PubMed ID: 31759261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunogenicity and protective capacity of leptospiral whole-cell monovalent serogroup Ballum vaccines in hamsters].
    González A; Rodríguez Y; Batista N; Valdés Y; Núñez JF; Mirabal M; González M
    Rev Argent Microbiol; 2005; 37(4):169-75. PubMed ID: 16502635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prime-boost strategy using the novel vaccine candidate, LemA, protects hamsters against leptospirosis.
    Hartwig DD; Forster KM; Oliveira TL; Amaral M; McBride AJ; Dellagostin OA
    Clin Vaccine Immunol; 2013 May; 20(5):747-52. PubMed ID: 23515012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of novel fusion proteins derived from extracellular matrix binding domains of LigB as vaccine candidates against leptospirosis in a hamster model.
    Cao Y; Faisal SM; Yan W; Chang YC; McDonough SP; Zhang N; Akey BL; Chang YF
    Vaccine; 2011 Oct; 29(43):7379-86. PubMed ID: 21803087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The serological response of working farm dogs to a vaccine containing Leptospira interrogans serovars Copenhageni and Pomona, and L. borgpetersenii serovar Hardjo.
    Cave NJ; Harland AL; Allott SK
    N Z Vet J; 2014 Mar; 62(2):87-90. PubMed ID: 24228620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination with leptospiral outer membrane lipoprotein LipL32 reduces kidney invasion of Leptospira interrogans serovar canicola in hamsters.
    Humphryes PC; Weeks ME; AbuOun M; Thomson G; Núñez A; Coldham NG
    Clin Vaccine Immunol; 2014 Apr; 21(4):546-51. PubMed ID: 24521782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterologous DNA prime-protein boost immunization with RecA and FliD offers cross-clade protection against leptospiral infection.
    Raja V; Sobana S; Mercy CSA; Cotto B; Bora DP; Natarajaseenivasan K
    Sci Rep; 2018 Apr; 8(1):6447. PubMed ID: 29691454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study on the efficacy of Leptospira vaccines developed from serovars isolated from Trinidad and comparison with commercial vaccines using a hamster model.
    Suepaul SM; Carrington CV; Campbell M; Borde G; Adesiyun AA
    Vaccine; 2010 Jul; 28(33):5421-6. PubMed ID: 20598785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterologous protection elicited by a live, attenuated, Leptospira vaccine.
    Murray GL; Simawaranon T; Kaewraemruaen C; Adler B; Sermswan RW
    Vet Microbiol; 2018 Sep; 223():47-50. PubMed ID: 30173751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration of immunity in dogs vaccinated against leptospirosis with a bivalent inactivated vaccine.
    Klaasen HL; Molkenboer MJ; Vrijenhoek MP; Kaashoek MJ
    Vet Microbiol; 2003 Aug; 95(1-2):121-32. PubMed ID: 12860082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of different strategies to promote a protective immune response against leptospirosis using a recombinant LigA and LigB chimera.
    da Cunha CEP; Bettin EB; Bakry AFAAY; Seixas Neto ACP; Amaral MG; Dellagostin OA
    Vaccine; 2019 Mar; 37(13):1844-1852. PubMed ID: 30826147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization against leptospirosis: vaccine trials with heat-killed whole cell and outer envelope antigens in hamsters.
    Zeigler JA; Jones RH; Kubica K
    Bull Pan Am Health Organ; 1976; 10(2):126-30. PubMed ID: 974302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimeric lipoproteins for leptospirosis vaccine: immunogenicity and protective potential.
    Tapajóz RCS; Santos FDS; de Oliveira NR; Maia MAC; Seixas Neto ACP; Maiocchi LV; Souza PHFC; Oliveira TL; Dellagostin OA
    Appl Microbiol Biotechnol; 2024 Jul; 108(1):424. PubMed ID: 39037584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental immunization of hamsters with an EDTA extract of Leptospira interrogans, serovar icterohaemorrhagiae.
    de Queiroz-Leite LT; Resende M; Ramos-Vieira M das N; Cota-Koury M
    Rev Latinoam Microbiol; 1996; 38(1):39-43. PubMed ID: 8783904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of leptospiral proteins that afford partial protection in hamsters against lethal challenge with Leptospira interrogans.
    Atzingen MV; Gonçales AP; de Morais ZM; Araújo ER; De Brito T; Vasconcellos SA; Nascimento ALTO
    J Med Microbiol; 2010 Sep; 59(Pt 9):1005-1015. PubMed ID: 20558583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OmpL1 DNA vaccine cross-protects against heterologous Leptospira spp. challenge.
    Maneewatch S; Tapchaisri P; Sakolvaree Y; Klaysing B; Tongtawe P; Chaisri U; Songserm T; Wongratanacheewin S; Srimanote P; Chongsa-nguanz M; Chaicumpa W
    Asian Pac J Allergy Immunol; 2007 Mar; 25(1):75-82. PubMed ID: 17891923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of protective efficacy, serological responses, and cytokine modulation induced by polyvalent Leptospira vaccines in hamsters.
    de Oliveira NR; Maia MAC; Santos FDS; Seixas Neto ACP; Oliveira Bohn TL; Dellagostin OA
    Comp Immunol Microbiol Infect Dis; 2024 May; 108():102159. PubMed ID: 38490118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.